GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » Operating Cash Flow per Share

Sunflower Pharmaceutical Group Co (SZSE:002737) Operating Cash Flow per Share : ¥-0.69 (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co Operating Cash Flow per Share?

Sunflower Pharmaceutical Group Co's operating cash flow per share for the three months ended in Mar. 2025 was ¥0.18. Sunflower Pharmaceutical Group Co's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.69.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sunflower Pharmaceutical Group Co was -148.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Sunflower Pharmaceutical Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 90.10% per year. The lowest was -34.00% per year. And the median was 9.10% per year.

SZSE:002737's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.85
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Sunflower Pharmaceutical Group Co Operating Cash Flow per Share Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co Operating Cash Flow per Share Chart

Sunflower Pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 1.49 3.37 1.53 -0.53

Sunflower Pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 -0.59 -0.44 0.16 0.18

Competitive Comparison of Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Sunflower Pharmaceutical Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunflower Pharmaceutical Group Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunflower Pharmaceutical Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sunflower Pharmaceutical Group Co's Price-to-Operating-Cash-Flow falls into.


;
;

Sunflower Pharmaceutical Group Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=-307.48/585.768
=-0.52

Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=101.711/571.118
=0.18

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sunflower Pharmaceutical Group Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunflower Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Executives
Zhou Jian Zhong Executives
Liu Tian Wei Director
Guan Yu Xiu Director
Wu Guo Xiang Executives
Ren Jing Shang Directors, executives
Guan Yan Bin Directors, executives
Wan Yun Guo Executives
Tian Yan Secretary Dong
Tan Chang Executives
Zhang Quan Director
Xu Qing Fen Supervisors
Jiang Feng He Supervisors
Wu Shu Hua Director
Guan Yan Ling Director

Sunflower Pharmaceutical Group Co Headlines

No Headlines